• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Infections

Posted inInfections, Research

Monkeypox 2022. Full Review

by Mark Gubar, Tanya von Reuss, Julia Mardi, Alex Avisoni and Timur Burkhanayev June 1, 2022April 11, 2024

Monkeypox as a new threat to humanity.

Posted inClinical Trials, Infections

Ycanth: First Treatment for Molluscum Contagiosum and Warts

by Tanya von Reuss May 25, 2022September 8, 2022

Cantharidin Verrica Pharmaceuticals can help get rid of common viral skin lesions.

helicobacter-pylori
Posted inInfections, Regulatory

Voquezna: New Drug for Acid-Related Gastrointestinal Diseases

by Mark Gubar May 2, 2022September 8, 2022

Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).

candida-albicans
Posted inInfections, New Drugs, Regulatory

Vivjoa: First Drug for Chronic Vaginal Yeast Infection

by Julia Mardi May 1, 2022September 8, 2022

Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.

proxalutamide
Posted inClinical Trials, COVID-19, Infections

Kropsen: Strong New Pill to Treat COVID-19 Infection

by Julia Mardi April 11, 2022September 8, 2022

Oral proxalutamide by Chinese Kintor Pharmaceutical effectively treats COVID-19 in outpatients and inpatients.

Posted inClinical Trials, COVID-19, Infections, Research

Favipiravir to Treat COVID-19. Most Comprehensive Review in World

by Julia Mardi, Mark Gubar and Timur Burkhanayev March 5, 2022September 8, 2022

What benefit we should expect from favipiravir in the fight against coronavirus?

Posted inClinical Trials, COVID-19, Infections

Upamostat: Oral Medication for COVID-19

by Mark Gubar March 3, 2022September 8, 2022

Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.

Posts pagination

Newer posts 1 2 3 4 5 6 … 9 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×